Key Takeaways
What Is the Cause of Postpartum Depression? There Is No Single One
What is the cause of postpartum depression? Research has not found a single one: the National Institute of Mental Health (NIMH) says perinatal depression "does not have a single cause" and that genetic and environmental factors both contribute[1]. Prevalence data by state and year are on the postpartum depression page.
NIMH lists three groups of contributing factors: life stress, the physical and emotional demands of childbirth and newborn care, and the hormone changes of pregnancy and the weeks after birth[1]. It also states that postpartum depression is not caused by anything a mother has or has not done[1]. MedlinePlus, the National Library of Medicine's consumer reference, likewise says the exact causes are unknown[6].
The most useful way to read the research is as vulnerability plus trigger. Childbirth brings the same steep hormone drop, broken sleep and new demands to almost everyone, yet most new mothers do not develop depression.
Studies of genes, hormone sensitivity, past depression and stressful circumstances help explain who does. Data on new parents overall are on the postpartum population page.
Postpartum depression
Depression that begins in the weeks and months after childbirth. NIMH groups it with prenatal depression under the term perinatal depression and says most episodes begin within 4 to 8 weeks after the baby is born[1]. It differs from the "baby blues," which NIMH describes as mild, short-lasting mood changes in the first 2 weeks after birth[1].
Related Terms
Source: National Institute of Mental Health
Do Hormones Cause Postpartum Depression?
Hormones look like a trigger, but only for some women. The clearest evidence is a 2000 experiment that recreated the hormone pattern of pregnancy and delivery in 16 women who were not pregnant: 8 with a past episode of postpartum depression and 8 without[2]. Researchers suppressed the women's own hormones, added back high doses of estradiol (the main estrogen) and progesterone for 8 weeks, then withdrew both under double-blind conditions[2].
During the withdrawal phase, 5 of the 8 women with a history of postpartum depression (62.5%) developed clinically significant mood symptoms, and none of the 8 comparison women did[2]. The authors concluded that these women appear to have a trait-like sensitivity to changing estradiol and progesterone levels[2]. The study was small, and it has not settled the question on its own.
A 2015 review co-authored by one of that study's investigators noted that several studies have found no link between measured hormone concentrations and postpartum depression[7]. Its explanation is that a subgroup of women seem to be particularly sensitive to normal perinatal changes in hormone levels[7]. The authors proposed treating this "hormone-sensitive" group as a distinct form of postpartum depression[7].
The same review lists other body systems that change after birth and may interact with reproductive hormones: thyroid function, immune function, the hypothalamic-pituitary-adrenal (HPA) stress axis, and lactation hormones[7].
Heritability of perinatal depression in a Swedish sibling study
Depression around pregnancy and birth was more heritable than depression at other times in the same population (32%), which suggests that some of the genetic risk is specific to the perinatal period.
"the heritability of perinatal depression was estimated at 44%"
Allopregnanolone and GABA: The Brain Chemistry Clue
Allopregnanolone is a neurosteroid, a steroid that acts directly on brain cells, and it targets GABA-A receptors, the brain's main inhibitory signaling system. A 2022 review reports that allopregnanolone starts below 20 nanomolar in early pregnancy, reaches 75 to 110 nanomolar for most women near term, and falls below 2 nanomolar by 4 to 6 weeks after birth[8].
That drop is a leading candidate trigger. The same review adds that it cannot be the whole explanation, because every woman goes through it and most do not develop postpartum depression[8]. All three authors list Sage Therapeutics, a pharmaceutical company, as their affiliation, which is worth knowing when weighing its framing[8].
The strongest support for this idea comes from treatment. Brexanolone, an intravenous formulation of allopregnanolone, was approved by the FDA in 2019 for postpartum depression[8][9].
Its label calls it a neuroactive steroid that boosts GABA-A receptor activity, and says its mechanism in postpartum depression "is not fully understood"[9]. NIMH notes that zuranolone, approved later as the first oral drug for postpartum depression, acts on similar receptors[1].
A drug that works through a pathway does not prove the pathway caused the illness. It is consistent with GABA signaling playing a role. How these drugs perform in trials is covered in postpartum depression treatment.
Is Postpartum Depression Genetic?
Partly. A 2016 Swedish study published in the American Journal of Psychiatry estimated the heritability of perinatal depression at 54% in a sample of 3,427 female twins, and at 44% in a larger sibling design, compared with 32% for depression at other times[3]. The twin estimate had a wide confidence interval of 35% to 70%[3].
The study also tested overlap. About a third of the genetic variance in perinatal depression (14% of the total variance) was not shared with depression outside the perinatal period[3]. In plain terms, most of the inherited risk is the same risk that raises depression in general, and a smaller part appears specific to pregnancy and birth.
A 2023 meta-analysis of genome-wide association studies (GWAS) pooled 18,770 postpartum depression cases and 58,461 controls[4]. No single variant reached genome-wide significance, and common variants together accounted for a SNP-based heritability of 0.14[4]. Postpartum depression showed genetic correlations with major depression, bipolar disorder, anxiety disorders, PTSD, insomnia, age at first period, and polycystic ovary syndrome[4].
That pattern means there is no "postpartum depression gene" to test for. Family history still matters in practice: NIMH says a personal or family history of depression or bipolar disorder raises the risk[1]. Heritability for depression in general is covered in Is depression genetic?
Which Risk Factors Have the Strongest Evidence?
Two umbrella reviews, which pool earlier meta-analyses, rank the risk factors. A 2020 review of 21 systematic reviews found 25 statistically significant risk factors[10]. The most common were high life stress, lack of social support, current or past abuse, prenatal depression, and marital or partner dissatisfaction[10].
That review named prenatal depression and current abuse as the two strongest risk factors[10]. Symptoms and screening during pregnancy are covered in prenatal depression.
A 2022 umbrella review in The British Journal of Psychiatry covered 185 observational studies with more than 3.2 million participants and graded each factor by strength of evidence[11]. Premenstrual syndrome had the strongest association (odds ratio 2.20), followed by violent experiences (2.07) and unintended pregnancy (1.53)[11].
No factor met the review's top tier of "convincing" evidence, and certainty was rated low or very low across the board[11]. Medically assisted conception and epidural pain relief during labor showed no significant association[11].
Risk Factors for Postpartum Depression by Strength of Evidence
| Factor | Odds ratio | Evidence class |
|---|---|---|
| Premenstrual syndrome | 2.20 | Highly suggestive |
| Violent experiences | 2.07 | Highly suggestive |
| Unintended pregnancy | 1.53 | Highly suggestive |
| Gestational diabetes | 1.60 | Suggestive |
| Cesarean section | 1.29 | Suggestive |
| Preterm delivery | 2.12 | Weak |
| Vitamin D deficiency | 3.67 | Weak |
| Anemia during pregnancy | 1.47 | Weak |
| Postpartum anemia | 1.75 | Weak |
Associations from an umbrella review of 185 observational studies, ranked by the credibility of the evidence rather than the size of the odds ratio[11].
1An odds ratio above one means the factor was more common among women with postpartum depression. A 'weak' class means the evidence is less reliable, even when the odds ratio is large.
2No factor reached the 'convincing' class, and GRADE certainty was low or very low for all factors[11].
Sources
- •Gastaldon et al., The British Journal of Psychiatry, 2022
Who Is Most at Risk? What U.S. Survey Data Show
CDC's Pregnancy Risk Assessment Monitoring System (PRAMS) surveyed women with a recent live birth at 31 sites in 2018[5]. Overall, 13.2% reported postpartum depressive symptoms[5]. The table below shows how that share differed by group.
The biggest gaps tracked earlier depression and violence. Postpartum symptoms were reported by 34.3% of women who had depression during pregnancy, compared with 9.9% of those who did not, and by 33.1% of women who had experienced intimate partner violence before or during pregnancy, compared with 12.5%[5]. Younger mothers also reported more symptoms: 22.2% at age 19 or under, compared with 10.8% at 35 or older[5].
MedlinePlus adds risk factors that the CDC table does not measure: an unplanned pregnancy or mixed feelings about it, money or housing problems, a poor relationship with a partner, and little support from family or friends[6]. These are cross-sectional associations, so they cannot show which came first. Symptom patterns are described in signs of postpartum depression.
Postpartum Depressive Symptoms by Characteristic, U.S., 2018
| Characteristic | With factor | Without factor |
|---|---|---|
| Depression during pregnancy | 34.3% | 9.9% |
| Intimate partner violence before or during pregnancy | 33.1% | 12.5% |
| Depression before pregnancy | 28.7% | 10.6% |
| Smoked in last 3 months of pregnancy | 22.3% | 12.4% |
| Preterm birth (under 37 weeks) vs. term | 17.1% | 12.8% |
Share of women with a recent live birth who reported postpartum depressive symptoms, 31 PRAMS sites, 2018[5].
1Symptoms were self-reported on a survey completed an average of about 4 months after birth; this is not a clinical diagnosis[5].
2Among women whose infant had died since birth, 48.7% reported depressive symptoms[5].
Sources
- •CDC PRAMS, MMWR 2020
Sleep, Birth Complications and the Body
Poor sleep is linked to postpartum depression, though the direction is hard to pin down. A 2023 meta-analysis of 16 studies covering 12,614 women found that sleep disorders during pregnancy were associated with higher odds of postpartum depression (odds ratio 2.36)[12]. The link held for poor sleep quality but not for insomnia, and only for sleep problems measured in the third trimester[12].
The studies varied widely in their results (heterogeneity of 84%), so the pooled figure is an estimate rather than a precise one[12]. Disrupted sleep can be an early symptom of depression as well as a possible contributor to it.
Birth and pregnancy complications show smaller or less certain links. Cesarean delivery and gestational diabetes had "suggestive" evidence in the 2022 umbrella review, and preterm delivery, anemia and vitamin D deficiency had "weak" evidence[11]. MedlinePlus notes that clinicians may order blood or urine tests to rule out a physical illness that causes depression[6].
Why Some Mothers Develop It and Others Do Not
Taken together, the evidence fits a vulnerability-plus-stress model. Inherited risk, past depression or a hormone-sensitive biology sets the vulnerability, and the hormone drop at delivery, sleep loss, violence, money problems or a lack of support act on it[7][10]. The general version of this model is explained in diathesis-stress theory.
The model also explains why timing varies. Some episodes begin during pregnancy and some months after birth, as described in when postpartum depression starts. Fathers can also develop depression after a birth without going through the maternal hormone shift; that research is summarized in can men get postpartum depression.
What the research cannot yet do is predict who will become depressed. Genetic studies have not found usable markers[4], and no single risk factor reaches the top evidence tier[11]. The causes of depression outside pregnancy are compared in what is the cause of depression.
Frequently Asked Questions
Sources & References
- National Institute of Mental Health. Perinatal Depression. National Institutes of Health. Published 2023. Accessed October 2026. https://www.nimh.nih.gov/health/publications/perinatal-depression [Link]
- Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of Gonadal Steroids in Women With a History of Postpartum Depression. American Journal of Psychiatry. Published 2000. Accessed October 2026. https://doi.org/10.1176/appi.ajp.157.6.924 [Link]
- Viktorin A, Meltzer-Brody S, Kuja-Halkola R, et al. Heritability of Perinatal Depression and Genetic Overlap With Nonperinatal Depression. American Journal of Psychiatry. Published 2016. Accessed October 2026. https://doi.org/10.1176/appi.ajp.2015.15010085 [Link]
- Guintivano J, Byrne EM, Kiewa J, et al. Meta-Analyses of Genome-Wide Association Studies for Postpartum Depression. American Journal of Psychiatry. Published 2023. Accessed October 2026. https://doi.org/10.1176/appi.ajp.20230053 [Link]
- Bauman BL, et al. Vital Signs: Postpartum Depressive Symptoms and Provider Discussions About Perinatal Depression — United States, 2018. MMWR Morb Mortal Wkly Rep. Centers for Disease Control and Prevention. Published 2020. Accessed October 2026. https://www.cdc.gov/mmwr/volumes/69/wr/mm6919a2.htm [Link]
- MedlinePlus. Postpartum depression. National Library of Medicine. Published 2024. Accessed October 2026. https://medlineplus.gov/ency/article/007215.htm [Link]
- Schiller CE, Meltzer-Brody S, Rubinow DR. The role of reproductive hormones in postpartum depression. CNS Spectrums. Published 2015. Accessed October 2026. https://doi.org/10.1017/S1092852914000480 [Link]
- Gunduz-Bruce H, Takahashi K, Huang MY. Development of neuroactive steroids for the treatment of postpartum depression. Journal of Neuroendocrinology. Published 2022. Accessed October 2026. https://doi.org/10.1111/jne.13019 [Link]
- U.S. Food and Drug Administration. ZULRESSO (brexanolone) injection: prescribing information. Drugs@FDA. Published 2022. Accessed October 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211371s007lbl.pdf [Link]
- Hutchens BF, Kearney J. Risk Factors for Postpartum Depression: An Umbrella Review. Journal of Midwifery & Women's Health. Published 2020. Accessed October 2026. https://doi.org/10.1111/jmwh.13067 [Link]
- Gastaldon C, Solmi M, Correll CU, Barbui C, Schoretsanitis G. Risk factors of postpartum depression and depressive symptoms: umbrella review of current evidence from systematic reviews and meta-analyses of observational studies. The British Journal of Psychiatry. Published 2022. Accessed October 2026. https://doi.org/10.1192/bjp.2021.222 [Link]
- Li H, Li H, Zhong J, et al. Association between sleep disorders during pregnancy and risk of postpartum depression: a systematic review and meta-analysis. Archives of Women's Mental Health. Published 2023. Accessed October 2026. https://doi.org/10.1007/s00737-023-01295-3 [Link]